Artiva Biotherapeutics, Inc To Start Trading Tomorrow
Artiva Biotherapeutics, Inc To Start Trading Tomorrow
Artiva Biotherapeutics, Inc (NASDAQ:ARTV) IPO will take place July, 19 on the NASDAQ exchange under the ticker ARTV.
Artiva Biotherapeutics，Inc（纳斯达克：ARTV）的IPO将于7月19日在纳斯达克交易所上市，代号为ARTV。
The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on January 15, 2025.
该公司发行股票的期望价格为每股14.00美元至16.00美元，内部人士锁定期为180天，截至2025年1月15日。
See also: Benzinga IPO Calendar
参见：Benzinga IPO日历
About Artiva Biotherapeutics, Inc
关于Artiva Biotherapeutics，Inc
Artiva Biotherapeutics, Inc is a clinical-stage biotechnology company focused on developing NK cell-based therapies for patients suffering from devastating autoimmune diseases and cancers.
Artiva Biotherapeutics，Inc是一家临床阶段的生物技术公司，专注于开发基于Nk细胞的治疗方案，用于治疗患有严重自身免疫性疾病和癌症的患者。
See also: Benzinga's Most Shorted Stocks
参见：Benzinga的做空集合股
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动化内容引擎生成并由编辑审查。